Some cookies are essential to the running of the website, while others (analytics) help us to make improvements. We also incorporate functionality from other websites, such as video, social media feeds and ReachDeck (text-to-speech and translations services) which may set cookies. More on how we use cookies
This website uses text-to-speech software called ReachDeck to read and / or translate its content. To use ReachDeck, you must allow ReachDeck cookies; the ReachDeck icon will then appear at the bottom right of your screen.
You can find out more about how ReachDeck uses cookies or change your cookie preferences at any time by going to our cookies page.
Allow ReachDeck cookies Do not use ReachDeck
If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).
Please find information on our services and visiting restrictions in our COVID-19 section.
Please see our latest guidance on face masks.
This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.
Sample type: CSF (Universal)
Collection requirements: No special requirements
Price on application
Please see Turnaround times
Immunoassay
John Radcliffe Hospital
Monitor CSF vancomycin trough levels prior to the second dose and thereafter on Mon/Wed/Fri in the morning (unless there are concerns regarding vancomycin distribution e.g. continuous CSF drainage, slit ventricles).
CNS trough levels are measured to determine if the dosage is adequate.
The target trough CSF vancomcyin level is 10 to 15 mg/L.
Intrathecal vancomycin has low toxicity, therefore the next dose can be given without awaiting the vancomcyin trough result.